BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2964931)

  • 1. [Biological studies and clinical application of the anti-migration factor in tumor diagnosis].
    Qu LR; Huang ZX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Aug; 9(4):262-5. PubMed ID: 2964931
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary studies on the physiochemical and biological properties of the tumor anti-migration factor].
    Qu LR; Huang ZX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Aug; 9(4):255-61. PubMed ID: 2964930
    [No Abstract]   [Full Text] [Related]  

  • 3. Response of a continuous macrophage-like cell line to MIF.
    Newman W; Diamond B; Flomenberg P; Scharff MD; Bloom BR
    J Immunol; 1979 Nov; 123(5):2292-7. PubMed ID: 385779
    [No Abstract]   [Full Text] [Related]  

  • 4. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kinetics of production of macrophage migration inhibitory factors in mixed culture of lymphocytes and tumor cells].
    Kharkevich DD; Suslov AP
    Biull Eksp Biol Med; 1982 Feb; 93(2):53-5. PubMed ID: 6461371
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of 51Cr-labelled macrophages for the objective evaluation of macrophage migration inhibition].
    Suslov AP; Miuller U
    Biull Eksp Biol Med; 1978 Jan; 85(1):54-7. PubMed ID: 342006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of mutant-specific responses by macrophage migration inhibition reactions induced by wild-type and mutant polyoma viruses and polyoma virus-infected cells.
    Szigeti R; Dalianis T; Ramqvist T; Ito Y; Klein G
    Cancer Res; 1984 Mar; 44(3):1077-80. PubMed ID: 6318980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation.
    Wu J; Cunha FQ; Liew FY; Weiser WY
    J Immunol; 1993 Oct; 151(8):4325-32. PubMed ID: 7691945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia virus-induced immunosuppression. IX. Depression of delayed hypersensitivity and MIF production after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1973 Dec; 111(6):1810-9. PubMed ID: 4584404
    [No Abstract]   [Full Text] [Related]  

  • 10. [Induction of T-cell producers of the macrophage migration inhibitory factor by the products of the K-, I- and D-regions of the H-2 complex in mice].
    Kharkevich DD; Suslov AP
    Biull Eksp Biol Med; 1985 Apr; 99(4):484-6. PubMed ID: 3886043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
    Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Migration inhibitory test and its clinical aspects].
    Dobozy A; Hunyadi J; Simon N
    Berufsdermatosen; 1973 Aug; 21(4):137-51. PubMed ID: 4583667
    [No Abstract]   [Full Text] [Related]  

  • 13. [Macrophage migration inhibition test in mice with experimental amyloidosis].
    Osipova IN
    Biull Eksp Biol Med; 1980 Apr; 89(4):433-5. PubMed ID: 6992881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the macrophage electrophoretic mobility test and the leukocyte migration inhibition test in the detection of histocompatibility antigens on tumor cells.
    Bubeník J; Cochran AJ; Todd G; Malkovský M; Jandlová T; Suhajová E; Boubelík M
    Neoplasma; 1981; 28(2):185-93. PubMed ID: 7019742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of macrophage migration inhibitory factor in the HEPES-buffered agarose medium. Modification of clausen's method].
    Nakagawa J; Okimoto Y; Era K; Ito K; Fukase M
    Ryumachi; 1974 Oct; 14(3):270-3. PubMed ID: 4375308
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of macrophage chemotaxis by supernatant fluid from malignant cell lines.
    Otu AA
    Afr J Med Med Sci; 1988 Dec; 17(4):215-20. PubMed ID: 2854368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIF as a glucocorticoid-induced modulator of cytokine production.
    Calandra T; Bernhagen J; Metz CN; Spiegel LA; Bacher M; Donnelly T; Cerami A; Bucala R
    Nature; 1995 Sep; 377(6544):68-71. PubMed ID: 7659164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced suppressor macrophage activity associated with termination of the L5178Y cell tumor-dormant state in DBA/2 mice.
    Robinson MK; Truitt GA; Okayasu T; Wheelock EF
    Cancer Res; 1983 Dec; 43(12 Pt 1):5831-6. PubMed ID: 6227383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage receptors for migration inhibitory factor (MIF), migration stimulatory factor (MSF), and agglutinating factor.
    Fox RA; Gregory DS; Feldman JD
    J Immunol; 1974 May; 112(5):1867-72. PubMed ID: 4594418
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of the lymphokine responsible for migration-inhibitory activity against tumor cells.
    Cohen MC
    Cancer Res; 1982 Jun; 42(6):2135-8. PubMed ID: 6978764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.